Clinical Trial

Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy

Study acronym: ImmuCCo
Recruiting
View on ClinicalTrials.gov →
Summary
ImmuCCo-1905 is a monocentric interventional study on patients treated by immunotherapy, which consist in establishment of a prospective clinic-biologic database over 5 years, associated with a biobank. This database will allow carrying out works aiming at assessing immunotherapy in real life situation.
Protocol Amendment History 1 change
notable Enrollment increased: 500 -> 651 participants 2026-03-31
Trial Details
NCT Number NCT05223608
Lead Sponsor Centre Oscar Lambret
Collaborators: Institut National de la Santé Et de la Recherche Médicale, France
Conditions Solid Tumor, Adult
Enrollment 651 participants
Start Date 2022-03-03
Primary Completion 2027-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-30